Endovascular Treatment of Transplant Renal Artery Stenosis: Evaluation of Postoperative Outcomes and Risk Factors for Recurrence.


Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 17 7 2018
medline: 18 6 2020
entrez: 17 7 2018
Statut: ppublish

Résumé

Angioplasty with or without stenting has become a well-established procedure to treat transplant renal artery stenosis (TRAS). We evaluated our experience on postoperative outcomes following the intervention and identified potential predictive factors of TRAS recurrence. Consecutive patients who underwent endovascular treatment of TRAS were retrospectively reviewed. The study end points were the technical success, 30-day postoperative complications, and the estimated glomerular filtration rate (eGFR). Thirty-two patients underwent endovascular treatment for TRAS. The technical success rate was 96.6%. Complications were observed for 7 (21.9%) patients: 4 had a dissection, 2 a pseudoaneurysm, and 1 (3.1%) patient developed an acute pulmonary edema. The mean eGFR significantly increased at 7 days, 3 months, and 6 months postintervention (43.1, 44.9, and 44.3 vs 33.9 mL/min/1.73 m

Identifiants

pubmed: 30009628
doi: 10.1177/0003319718787665
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-256

Auteurs

François-René Roustan (FR)

Department of Urology, University Hospital of Nice, Nice, France.
Université Côte d'Azur, CHU, Inserm, C3M, Nice, France.

Fabien Lareyre (F)

Université Côte d'Azur, CHU, Inserm, C3M, Nice, France.
Department of Vascular Surgery, University Hospital of Nice, Nice, France.

Imad Bentellis (I)

Department of Urology, University Hospital of Nice, Nice, France.

Romain Haider (R)

Department of Urology, University Hospital of Nice, Nice, France.

Stéphanie Torrino (S)

Université Côte d'Azur, CHU, Inserm, C3M, Nice, France.

Jacques Sedat (J)

Department of Interventional Radiology, University Hospital of Nice, Nice, France.

Laetitia Albano (L)

Department of Nephrology, University Hospital of Nice, Nice, France.

Elixène Jean-Baptiste (E)

Université Côte d'Azur, CHU, Inserm, C3M, Nice, France.
Department of Vascular Surgery, University Hospital of Nice, Nice, France.

Juliette Raffort (J)

Université Côte d'Azur, CHU, Inserm, C3M, Nice, France.
Clinical Chemistry Laboratory, University Hospital of Nice, Nice, France.

Matthieu Durand (M)

Department of Urology, University Hospital of Nice, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH